---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-077250"
form_type: "8-K"
ticker: "PHGE"
cik: "0001739174"
company_name: "BiomX Inc."
filed_at: "2026-07-10T21:10:14+00:00"
generated_at: "2026-07-10T21:12:04.021003+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# BiomX cancels 1.01M shares to comply with NYSE American stockholder approval rule

## Summary
- 1,013,637 restricted shares issued on June 2, 2026 upon conversion of $379,000 promissory note under a line of credit.
- NYSE American determined the acquisition and line of credit are related transactions requiring shareholder approval under Section 712.
- All 1,013,637 shares were cancelled on July 10, 2026 and returned to treasury to regain compliance.
- Company will seek stockholder approval at a future meeting; no assurance of obtaining approval.
- Failure to obtain approval could lead to further NYSE American action regarding listing of PHGE common stock.

## SEC filing metadata
- accession: 0001213900-26-077250
- form_type: 8-K
- ticker: PHGE
- cik: 0001739174
- company_name: BiomX Inc.
- filed_at: 2026-07-10T21:10:14+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1739174/000121390026077250/0001213900-26-077250-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1739174/000121390026077250/ea0297633-8k_biomx.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-077250
- JSON: https://secwatch.observer/filing/0001213900-26-077250.json
- Plain text: https://secwatch.observer/filing/0001213900-26-077250.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.